Articles From: Genworth Holdings Prices $400 Million Debt Offering to Genzyme Receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) Application


2013/8/5
RICHMOND, Va.
Sign-up for Genworth Holdings Prices $400 Million Debt Offering investment picks
RICHMOND, Va.
Sign-up for Genworth Holdings Prices $400 Million Senior Notes Offering investment picks
Offers an optional rider for coverage of long term care services RICHMOND, Va.
Sign-up for Genworth Introduces Flexible, Affordable Index Universal Life Insurance investment picks
2013/10/29
Genworth MI Canada Inc. Announces 9% Dividend Payment Increase In the Fourth Quarter 2013 Canada NewsWire TORONTO , Oct.
Sign-up for Genworth MI Canada Inc. Announces 9% Dividend Payment Increase In the Fourth Quarter 2013 investment picks
Genworth MI Canada Inc. Announces Resignation and Appointment of Director Canada NewsWire TORONTO , Sept.
Sign-up for Genworth MI Canada Inc. Announces Resignation and Appointment of Director investment picks
2014/4/1
Genworth MI Canada Inc. Completes $160 Million Senior Unsecured Debenture Offering Canada NewsWire /THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR TRANSMITTED IN OR INTO THE UNITED STATES OR OVER UNITED STATES WIRE OR NEWS SERVICES./ TORONTO , April 1, 2014 /CNW/ - Genworth MI Canada Inc. (the "Company") (TSX: MIC) announced today that it has completed its previously announced offering of $160 million of 4.242% debentures due April 1, 2024 (the "Debentures").  The offering was made through a syndicate of agents led by Scotiabank, BMO Capital Markets, RBC Capital Markets and TD Securities Inc. The Debentures have been rated A- by Standard & Poor's and AA(low) by DBRS.
Sign-up for Genworth MI Canada Inc. Completes $160 Million Senior Unsecured Debenture Offering investment picks
2014/3/21
Genworth MI Canada Inc. Considering Debenture Offering Canada NewsWire /THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR TRANSMITTED IN OR INTO THE UNITED STATES OR OVER UNITED STATES WIRE OR NEWS SERVICES./ TORONTO , March 21, 2014 /CNW/ - Genworth MI Canada Inc. (the "Company") (TSX: MIC) announced today that it is considering a debenture offering pursuant to its base shelf prospectus.
Sign-up for Genworth MI Canada Inc. Considering Debenture Offering investment picks
2014/2/4
Genworth MI Canada Inc. Reports Fourth Quarter 2013 Earnings And Full Year Results Canada NewsWire Fourth Quarter Net Operating Income of $85 million , Operating Diluted EPS of $0.90 per share Full Year Net Operating Income of $349 million , Full Year Diluted Operating EPS of $3.60 per share Full Year Operating EPS up 5% Full Year Operating Return on Equity of 12% TORONTO , Feb.
Sign-up for Genworth MI Canada Inc. Reports Fourth Quarter 2013 Earnings And Full Year Results investment picks
Genworth MI Canada Inc. Reports Third Quarter 2013 Earnings Canada NewsWire Net Operating Income of $91 million , 12% higher year-over-year Operating Diluted EPS of $0.94 /share, 15% higher year-over-year Common Dividend Increase of 9% to $0.35 per share TORONTO , Oct.
Sign-up for Genworth MI Canada Inc. Reports Third Quarter 2013 Earnings investment picks
2014/4/3
Genworth MI Canada Inc. Schedules First Quarter 2014 Earnings Conference Call for April 30, 2014 Canada NewsWire TORONTO , April 3, 2014 /CNW/ - Genworth MI Canada Inc. (the "Company") (TSX: MIC) today announced it will issue its earnings release and financial supplement containing the first quarter results after the market closes on April 29 , 2014.
Sign-up for Genworth MI Canada Inc. Schedules First Quarter 2014 Earnings Conference Call for April 30, 2014 investment picks
Genworth MI Canada Inc. Schedules Third Quarter 2013 Earnings Conference Call for October 30, 2013 Canada NewsWire TORONTO , Oct.
Sign-up for Genworth MI Canada Inc. Schedules Third Quarter 2013 Earnings Conference Call for October 30, 2013 investment picks
2014/3/26
Genworth MI Canada Inc. to Issue $160 Million Senior Unsecured Debentures Canada NewsWire /THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR TRANSMITTED IN OR INTO THE UNITED STATES OR OVER UNITED STATES WIRE OR NEWS SERVICES./ TORONTO , March 26, 2014 /CNW/ - Genworth MI Canada Inc. (the "Company") (TSX: MIC) announced today that it has agreed to issue $160 million of debentures (the "Debentures").  The Debentures will be senior direct and unsecured obligations of the Company and will rank equally with all other unsecured and unsubordinated indebtedness of the Company.
Sign-up for Genworth MI Canada Inc. to Issue $160 Million Senior Unsecured Debentures investment picks
2014/4/1
Genworth MI Canada Inc. to Redeem the $150 Million 4.59% Debentures due December 15, 2015 on May 1, 2014 Canada NewsWire TORONTO , April 1, 2014 /CNW/ - Genworth MI Canada Inc. (the "Company") (TSX: MIC) announced today that it will redeem in full the 4.59% debentures (the "Debentures") of the Company due December 15 , 2015.The Company has given a notice to the registered holder of the Debentures that it will redeem on May 1, 2014 (the "Redemption Date"), the full $150 million principal amount outstanding of the Debentures.
Sign-up for Genworth MI Canada Inc. to Redeem the $150 Million 4.59% Debentures due December 15, 2015 on May 1, 2014 investment picks
2014/4/9
Committed to Being Available on Leading Origination Platforms Used by Customers RICHMOND, Va.
Sign-up for Genworth MI Launches Integration with Optimal Blue Product and Pricing Engine; Offers Loan Originators More Functionality than Competitors investment picks
2014/1/31
RICHMOND, Va.
Sign-up for Genworth Names James Boyle President and CEO -- U.S. Life Insurance Division investment picks
RICHMOND, Va.
Sign-up for Genworth Names Lori M. Evangel Chief Risk Officer investment picks
2013/8/27
Productivity App for Loan Originators and Processors Using Smart Phones, Tablets RICHMOND, Va.
Sign-up for Genworth U.S. Mortgage Insurance Introduces Mobile Version of Rate Express to Help On-the-Go Lenders Close Loans Faster investment picks
Helps Meet Need for Underwriters Able to Evaluate Loans for Today's Purchase Market RICHMOND, Va.
Sign-up for Genworth U.S. Mortgage Insurance Redesigns MBA's Certified Residential Underwriter Training Courses to Reflect Market, Regulatory Changes investment picks
2013/9/16
Simply Underwrite(SM) Guidelines Closely Align Coverage with GSE AUS Approvals RICHMOND, Va.
Sign-up for Genworth U.S. Mortgage Insurance Reduces Rates, Expands Guidelines to Help Lenders Meet Needs of the Growing Home Purchase Market investment picks
2014/2/25
Information Helps Customers Consider Effects on Operating and Servicing Processes RICHMOND, Va.
Sign-up for Genworth USMI Provides New Master Policy Resources to Help Customers Understand Improved Coverage Benefits and Plan for Operational Impacts investment picks
2014/1/13
- Genzyme to Obtain Significant Global Rights to Alnylam's Pipeline - Conference Call Information Alnylam and Genzyme management will discuss this new alliance in a conference call on January 13, 2014 at 9:00 am ET (6:00 am PT).  A slide presentation will also be available on the News & Investors page of the company's website, www.alnylam.com , to accompany the conference call.
Sign-up for Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases investment picks
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), and the National Organization for Rare Disorders (NORD) today announced the creation of a fund to pay for standard diagnostic testing for people with mysterious, undiagnosed medical conditions.
Sign-up for Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases investment picks
2013/9/30
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the recipients of the 2013 Genzyme Patient Advocacy Leadership (PAL) Awards.
Sign-up for Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards investment picks
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the fifth annual Gaucher Leadership Forum (GLF) will take place on November 22 and 23 in Madrid, Spain.
Sign-up for Genzyme Convenes 5th Annual Gaucher Leadership Forum in Madrid investment picks
2014/3/26
Alnylam Pharmaceuticals, Inc .
Sign-up for Genzyme Exercises its Right to Purchase Additional Shares of Alnylam Common Stock investment picks
Genzyme , a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
Sign-up for Genzyme Receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) Application investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Genworth Holdings Prices $400 Million Debt Offering to Genzyme Receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) Application
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity